Metraipolis › archive › dc_09b5e18783be

Intralesional versus intracoronary administration of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention in patients with acute… — Europe PMC PMID:28984776

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/28984776
DOI
10.1097/md.0000000000008223
License (as archived)
solo-consultazione
Archived
2026-11-08T08:10:08.154Z
SHA-256 of the archived text
76363c62dd48176a19403de8fa43e8bec1dc4afd7a4d6f06d14e44a596194e67
Stable URL of this page
https://metraipolis.com/documento/dc_09b5e18783be

How to cite

Intralesional versus intracoronary administration of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention in patients with acute… — Europe PMC PMID:28984776 — Europe PMC (en), https://europepmc.org/article/MED/28984776 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_09b5e18783be (Metraipolis archive dc_09b5e18783be, sha256 76363c62dd48176a19403de8fa43e8bec1dc4afd7a4d6f06d14e44a596194e67)
BibTeX
@misc{dc09b5e18783be,
  title = {Intralesional versus intracoronary administration of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention in patients with acute… — Europe PMC PMID:28984776},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/28984776},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_09b5e18783be; sha256 76363c62dd48176a19403de8fa43e8bec1dc4afd7a4d6f06d14e44a596194e67},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/28984776. Agents can read the archived copy with the MCP tool read_document.